Patients with a history of atrial fibrillation (AFib) are more likely to experience adverse outcomes within two years of transcatheter aortic valve replacement (TAVR), according to new research published in the American Journal of Cardiology.[1] The study’s authors explored data from more than 900 patients with severe aortic stenosis who underwent TAVR from 2012 to 2020. Approximately 35% of…
While most TAVR-related reinterventions occurred in the first year after treatment, most SAVR-related reinterventions occurred in years two through five. The team’s full analysis is…
The three-day event will include sessions about sexual activity among heart patients, depression, energy drinks, stimulants, vaccines and more. The festivities begin Thursday, April 25,…
Biga, who originally trained as a nurse, specializes in the business side of cardiology. She also emphasized the increasing importance of AI and other new…
“The alleged conduct of this physician is so egregious, only the permanent revocation of his license could adequately protect the public from the risks posed…
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky and transcaval access was the best path forward.
Alexander Fanaroff, MD, said the late-breaking BE ACTIVE clinical trial presented at ACC.24 offers a blueprint for how to get patients to be more physically…
The issue at the center of this recall, which includes both the HeartMate II and HeartMate 3 LVAD, is the gradual buildup of biological materials.…
The popular high-fat, low-carb diet is associated with multiple short-term benefits, but they appear to diminish over time.
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky and transcaval access was the best path forward.
Ask Bio, acquired by Bayer for more than $2 billion in 2020, is enrolling patients for a new clinical trial focused on the therapy’s effectiveness in…
